Hympavzi Injection, Solution
Product Images NDC 0069-1510

Product Visual Gallery

This gallery contains 29 technical images submitted to the FDA as part of the official labeling for Hympavzi (NDC 0069-1510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pfizer Laboratories Div Pfizer Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – 150 mg/ml Prefilled Pen (Hympavzi 01)

Label for HYMPAVZI 150 mg/mL injection prefilled pen by Pfizer Laboratories Div Pfizer Inc. The label includes the proprietary name HYMPAVZI, the active ingredient marstacimab-hncq, and states it is for subcutaneous use only. It advises storage refrigerated at 36°F to 46°F (2°C to 8°C) and instructs not to shake. The label contains lot, expiration, and barcode information.*

FDA Label Image

Principal Display Panel – 150 mg/ml Prefilled Pen Carton (Hympavzi 02)

Packaging label for HYMPAVZI 150 mg/mL injection, a single-dose prefilled pen for subcutaneous use. The label features the proprietary name HYMPAVZI with the active ingredient marstacimab-hcnq, includes usage instructions and storage information, and identifies Pfizer Laboratories Div Pfizer Inc as the manufacturer and distributor. The carton also includes barcodes and various regulatory markings.*

FDA Label Image

Pfizer Logo (Marstacimab 01)

FDA Label Image

Pfizer Logo (Marstacimab 02)

FDA Label Image

Syringe Supplies (Marstacimab 03)

An instructional illustration showing a HYMPAVZI prefilled syringe alongside an alcohol swab, a cotton ball or gauze pad, and a sharps disposal container. The image highlights components commonly used for injection preparation and safe disposal.*

FDA Label Image

Syringe Before And After (Marstacimab 04)

An instructional diagram showing the HYMPAVZI prefilled syringe before and after use. The syringe components labeled before use include needle cover, barrel, label, plunger rod, and finger grip. After use, the syringe is shown with the needle exposed and the gray plunger stopper visible.*

FDA Label Image

Syringe Step 2 (Marstacimab 05)

An instructional illustration showing a hand holding a small vial or syringe labeled with a lot number and expiration date. The image highlights Step 2: Check Expiration Date, emphasizing the importance of verifying the product's lot number and expiration before use.*

FDA Label Image

Syringe Step 3 (Marstacimab 06)

Illustration showing a hand holding a prefilled syringe, labeled as Step 3 'Check Medicine.' The syringe contains liquid medicine and is shown with a needle cover on the tip, demonstrating the step of inspecting the syringe before use.*

FDA Label Image

Syringe Step 4 (Marstacimab 07)

Instructional illustration titled 'Choose and Clean Your Injection Site.' It depicts the front and back of a human torso highlighting injection areas: shaded regions on the outer thighs and the abdomen at least 2 inches away from the belly button. The back view shows upper arm areas marked for injection by healthcare providers or caregivers only.*

FDA Label Image

Syringe Step 5 (Marstacimab 08)

An instructional illustration labeled Step 5 demonstrating the removal of a cover from a syringe and the insertion of a cap into a circular device. The image shows a hand lifting the syringe cover upward and another hand placing the cap into the device with a downward arrow indicating direction.*

FDA Label Image

Syringe Step 6 (Marstacimab 09)

An instructional illustration labeled Step 6 showing how to insert a needle at a 45-degree angle into the skin. The image depicts a syringe held by one hand and the other hand stretching the skin, with an arrow indicating the direction of needle insertion.*

FDA Label Image

Syringe Step 7 (Marstacimab 10)

An instructional illustration showing Step 7 for administering medicine via injection. It depicts a hand holding a syringe with the needle inserted into the skin of another hand, indicated by an arrow pointing downward toward the plunger to inject the medicine.*

FDA Label Image

Syringe Step 8 (Marstacimab 11)

Illustration showing Step 8 in an injection process for HYMPAVZI. It depicts a hand removing the needle from the injection site on another person's arm, with an upward arrow indicating the needle's removal direction.*

FDA Label Image

Syringe Step 9 (Marstacimab 12)

An instructional illustration showing Step 9: Check Syringe. The image depicts a hand holding a syringe, focusing on verifying the syringe contents or setup. This is part of a multi-step procedure likely related to administering or preparing HYMPAVZI medication.*

FDA Label Image

Syringe Step 10 (Marstacimab 13)

Illustration showing Step 10 labeled 'After Care,' depicting a hand holding a piece of cotton or gauze, indicating a post-procedure care action likely related to the use of HYMPAVZI.*

FDA Label Image

Syringe Step 11 (Marstacimab 14)

An instructional illustration showing Step 11 for disposal of a syringe. The image depicts a hand holding a syringe with a plunger, positioned over a sharps disposal container. A caution symbol indicates not to recap the syringe needle before disposal.*

FDA Label Image

Pfizer Logo (Marstacimab 15)

FDA Label Image

Pen Supplies (Marstacimab 16)

Illustration showing components of the HYMPAVZI prefilled pen system, including the pen device, an alcohol swab, a cotton ball or gauze pad, and a sharps disposal container for safe needle disposal.*

FDA Label Image

Pen Before And After (Marstacimab 17)

An instructional diagram showing the HYMPAVZI prefilled pen before and after use. The pre-use image labels the cap, needle cover, unlocked needle guard, needle inside guard, window, expiration date, and dose strength. The post-use image labels the locked needle guard, plunger, and yellow bar in the window.*

FDA Label Image

Pen Step 2 (Marstacimab 18)

Illustration showing step 2 of a procedure involving a HYMPAVZI injection pen, highlighting how to check the expiration date on the label, with a close-up of the lot number and expiration date formatted as YYYY MMM DD.*

FDA Label Image

Pen Step 3 (Marstacimab 19)

An instructional diagram illustrating Step 3 titled 'Check Medicine.' It shows a close-up of a hand peeling back part of a packaging or label to visually inspect a small vial or ampule of medication inside, emphasizing verification of the medicine before use.*

FDA Label Image

Pen Step 4 (Marstacimab 20)

An instructional diagram labeled Step 4 illustrating recommended injection sites for HYMPAVZI. It highlights the stomach area (abdomen) with a note to keep injections at least 2 inches away from the belly button, the thigh, and the buttocks. It specifies that injections in the buttocks should be administered by a healthcare provider or caregiver only.*

FDA Label Image

Pen Step 5 (Marstacimab 21)

Instructional diagram labeled Step 5 demonstrating the removal of a cap by twisting it off. The illustration shows hands gripping and twisting a cap off a container or device, indicated by blue arrows showing the direction of the twist and the cap's removal.*

FDA Label Image

Pen Step 6 (Marstacimab 22)

An instructional diagram illustrating Step 6 of injecting the medicine for HYMPAVZI. It shows how to push down firmly and keep pushing the syringe until two clicks are heard, followed by counting to five as indicated by an hourglass timer icon.*

FDA Label Image

Pen Step 7 (Marstacimab 23)

An instructional diagram labeled 'Step 7 Remove Pen' showing a hand holding a pen-like device with the thumb and fingers around it, and a blue arrow pointing upwards indicating the pen should be pulled up and removed.*

FDA Label Image

Pen Step 8 (Marstacimab 24)

An instructional illustration labeled Step 8, showing a close-up of a check window on a device containing a yellow liquid. A hand is partially visible interacting with the device, emphasizing the importance of checking the liquid in the window as part of the process.*

FDA Label Image

Pen Step 9 (Marstacimab 25)

An instructional illustration labeled Step 9, titled 'After Care,' shows a hand holding a gauze or cotton pad, typically indicating a post-procedure care step such as applying pressure or cleaning a site.*

FDA Label Image

Pen Step 10 (Marstacimab 26)

Illustration titled 'Step 10 Disposal of Pen' showing a hand discarding a used injection pen into a round, lidded sharps disposal container. The pen has a white body with a blue cap and a visible yellow band near the middle, emphasizing safe disposal practices.*

FDA Label Image

Pfizer Logo (Marstacimab 27)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.